Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1992;85:543-553

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leclerc, G.
Right arrow Articles by Weir, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leclerc, G.
Right arrow Articles by Weir, L.
Right arrowPubmed/NCBI databases
*Substance via MeSH

Circulation, Vol 85, 543-553, Copyright © 1992 by American Heart Association


ARTICLES

Evidence implicating nonmuscle myosin in restenosis. Use of in situ hybridization to analyze human vascular lesions obtained by directional atherectomy

G Leclerc, JM Isner, M Kearney, M Simons, RD Safian, DS Baim and L Weir
Department of Medicine (Cardiology Division), St. Elizabeth's Hospital, Tufts University School of Medicine, Boston, Mass.

BACKGROUND. Identification of genes that are specifically activated in restenosis lesions after percutaneous transluminal angioplasty represents a necessary step toward molecular manipulation designed to inhibit cellular proliferation responsible for such lesions. Whereas quiescent smooth muscle cells (contractile phenotype) preferentially express smooth muscle myosin, proliferating smooth muscle cells (synthetic phenotype) have been shown to preferentially express nonmuscle myosin in vitro. Accordingly, we analyzed the expression of a recently cloned isoform of human nonmuscle myosin heavy chain (MHC-B) in fresh human restenotic lesions. METHODS AND RESULTS. A total of 10 lesions, including four restenosis (three superficial femoral arterial lesions and one saphenous vein bypass lesion) and six primary (four superficial femoral arterial lesions and two coronary arterial lesions) obtained percutaneously by directional atherectomy, were processed for examination by in situ hybridization. In total, 150 tissue sections of restenotic lesions (66 sections), primary lesions (78 sections), and normal internal mammary artery (six sections) were hybridized with the nonmuscle MHC-B probe. Restenotic lesions showed intense hybridization to the nonmuscle MHC-B cRNA probe, as demonstrated by a clustering of more than 20 grains per cell nucleus in 80% of the cells examined within a high-power field (x250); in contrast, an equivalent degree of hybridization was observed in only 7% of cells within primary lesions (p less than 0.001). Results of immunocytochemistry using monoclonal antibody to smooth muscle actin indicated that cells demonstrating strong hybridization were smooth muscle in origin. CONCLUSIONS. These findings demonstrate that 1) human vascular tissue obtained by percutaneous directional atherectomy constitutes appropriate biopsy material for gene expression studies at the mRNA level, and 2) nonmuscle MHC-B mRNA is present in greater abundance among restenotic versus primary vascular stenoses. These observations thus provide a rational basis to explore restenotic lesions on a larger scale to identify genes that are activated in these lesions and establish potential targets for future gene therapy.


This article has been cited by other articles:


Home page
Mol Hum ReprodHome page
F. Pelliccione, G. Cordeschi, M. Bocchio, M. Mancini, P. Sagone, F. Francavilla, G.M. Colpi, and S. Francavilla
Immunophenotypical characterization of contractile cells in caput epididymidis of men affected by congenital or post-inflammatory obstructive azoospermia
Mol. Hum. Reprod., April 1, 2005; 11(4): 289 - 294.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Sai, A. Iwata, R. Thomas, and M. D. Allen
Vascular cell adhesion molecule-1 up-regulation and phenotypic modulation of vascular smooth muscle cells predate mononuclear infiltration in transplant arteriopathy
J. Thorac. Cardiovasc. Surg., September 1, 2001; 122(3): 508 - 517.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
P. J. Gallagher, Y. Jin, G. Killough, E. K. Blue, and V. Lindner
Alterations in expression of myosin and myosin light chain kinases in response to vascular injury
Am J Physiol Cell Physiol, October 1, 2000; 279(4): C1078 - C1087.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Pauletto, M. Puato, E. Faggin, N. Santipolo, V. Pagliara, M. Zoleo, G. P. Deriu, F. Grego, M. Plebani, S. Sartore, et al.
Specific Cellular Features of Atheroma Associated With Development of Neointima After Carotid Endarterectomy : The Carotid Atherosclerosis and Restenosis Study
Circulation, August 15, 2000; 102(7): 771 - 778.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. P. Herring, A. M. Hoggatt, A. F. Smith, and P. J. Gallagher
Targeted Expression of SV40 Large T-antigen to Visceral Smooth Muscle Induces Proliferation of Contractile Smooth Muscle Cells and Results in Megacolon
J. Biol. Chem., June 18, 1999; 274(25): 17725 - 17732.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. G. Frid, E. C. Dempsey, A. G. Durmowicz, and K. R. Stenmark
Smooth Muscle Cell Heterogeneity in Pulmonary and Systemic Vessels : Importance in Vascular Disease
Arterioscler. Thromb. Vasc. Biol., July 1, 1997; 17(7): 1203 - 1209.
[Abstract] [Full Text]


Home page
CirculationHome page
M. Aikawa, Y. Sakomura, M. Ueda, K. Kimura, I. Manabe, S. Ishiwata, N. Komiyama, H. Yamaguchi, Y. Yazaki, and R. Nagai
Redifferentiation of Smooth Muscle Cells After Coronary Angioplasty Determined via Myosin Heavy Chain Expression
Circulation, July 1, 1997; 96(1): 82 - 90.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
H. De Leon, N. A. Scott, F. Martin, L. Simonet, K. E. Bernstein, and J. N. Wilcox
Expression of Nonmuscle Myosin Heavy Chain-B Isoform in the Vessel Wall of Porcine Coronary Arteries After Balloon Angioplasty
Circ. Res., April 19, 1997; 80(4): 514 - 519.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
J. K. Belknap, N. A. Grieshaber, P. E. Schwartz, E. C. Orton, M. A. Reidy, and R. A. Majack
Tropoelastin Gene Expression in Individual Vascular Smooth Muscle Cells : Relationship to DNA Synthesis During Vascular Development and After Arterial Injury
Circ. Res., March 1, 1996; 78(3): 388 - 394.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
S. M. Schwartz, D. deBlois, and E. R. M. O'Brien
The Intima : Soil for Atherosclerosis and Restenosis
Circ. Res., September 1, 1995; 77(3): 445 - 465.
[Full Text]


Home page
Circ. Res.Home page
C. J. Pastore, J. M. Isner, P. A. Bacha, M. Kearney, and J. G. Pickering
Epidermal Growth Factor Receptor–Targeted Cytotoxin Inhibits Neointimal Hyperplasia In Vivo : Results of Local Versus Systemic Administration
Circ. Res., September 1, 1995; 77(3): 519 - 529.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
L. Weir, D. Chen, C. Pastore, J. M. Isner, and K. Walsh
Expression of gax, a Growth Arrest Homeobox Gene, Is Rapidly Down-regulated in the Rat Carotid Artery during the Proliferative Response to Balloon Injury
J. Biol. Chem., March 10, 1995; 270(10): 5457 - 5461.
[Abstract] [Full Text] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
N. Cavallari, R. J. Feldhaus, J. E. McGill, M. Anselmino, and A. Mingoli
Peripheral Directional Atherectomy: Arteriographic vs Hemodynamic Assessment of Cumulative Patency
Vascular and Endovascular Surgery, June 1, 1993; 27(5): 329 - 336.
[Abstract] [PDF]


Home page
NEJMHome page
M. Simons, G. Leclerc, R. D. Safian, J. M. Isner, L. Weir, and D. S. Baim
Relation between Activated Smooth-Muscle Cells in Coronary-Artery Lesions and Restenosis after Atherectomy
N. Engl. J. Med., March 4, 1993; 328(9): 608 - 613.
[Abstract] [Full Text]